Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Daiichi Sankyo
Boehringer Ingelheim
UBS
McKesson
Cantor Fitzgerald
Cerilliant
Queensland Health

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085827

« Back to Dashboard

NDA 085827 describes HYDRALAZINE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the HYDRALAZINE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in HYDRALAZINE AND HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
Summary for 085827
Tradename:HYDRALAZINE AND HYDROCHLOROTHIAZIDE
Applicant:Watson Labs
Ingredient:hydralazine hydrochloride; hydrochlorothiazide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;15MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Cerilliant
Fuji
Johnson and Johnson
Daiichi Sankyo
Chubb
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.